# Oxford Nanopore appoints David Miller as Chief Development and Product Officer

- Link: https://www.directorstalkinterviews.com/oxford-nanopore-appoints-david-miller-as-chief-development-and-product-officer/4121261121
- Published: 2026-08-25T07:24:14+01:00
- Author: Ethan Davis

**Oxford Nanopore Technologies Plc** (LON:ONT) has announced the appointment of 
David Miller as Chief Development and Product Officer (CDPO), joining on 1^(st) 
September. The company also confirms that Conor McKechnie will join as Chief Marketing
and Communications Officer (CMCO) on 1^(st) October, as previously announced.

Together, these appointments strengthen Oxford Nanopore’s leadership team, bringing
greater alignment between product development, market positioning and commercial
execution.

As CDPO, David will lead Product Management, Development and Applications, strengthening
the connection between the company’s strategy, development priorities and product
portfolio. David joins Oxford Nanopore from Pacific Biosciences, where he served
as Head of Research & Development and Vice President, Global Marketing. Prior to
that, he held senior product leadership roles at Illumina, including responsibility
for major platform launches.

As CMCO, Conor will lead Oxford Nanopore’s global Marketing and Corporate Affairs
functions, with responsibility for strengthening market positioning, customer engagement
and the company’s corporate and technology narratives. Conor joins from Cytiva, 
where he has served as Group Vice President, Marketing. He previously held senior
marketing, communications and public affairs roles at GE Healthcare.

> **Francis Van Parys, Chief Executive Officer of Oxford Nanopore, commented:**
> “As we scale Oxford Nanopore, we are strengthening our leadership team to deepen
> our focus on customers and accelerate the translation of our differentiated technology
> into high-performing products, applications and successful customer adoption. 
> David and Conor bring deep experience across product development, commercialisation,
> customer and market adoption, and will play important roles as we increase our
> focus on disciplined execution and sustainable growth.”

> **David Miller said:**
> “Oxford Nanopore has built a truly differentiated technology platform with enormous
> potential. I’m excited by the opportunity to bring together product development
> and applications to turn that innovation into high-performing products and solutions
> that solve important problems for customers.”

> **Conor McKechnie said:**
> “Oxford Nanopore has an exceptional technology platform and a significant opportunity
> across Research, Clinical and BioPharma. I’m looking forward to working with the
> team to strengthen how we engage with customers and stakeholders, build understanding
> of the value Oxford Nanopore can deliver, and support the company’s next phase
> of growth.”

Both David and Conor will join Oxford Nanopore’s Executive team.

Share on: